A detailed history of Victory Capital Management Inc transactions in Neogenomics Inc stock. As of the latest transaction made, Victory Capital Management Inc holds 24,403 shares of NEO stock, worth $419,243. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,403
Previous 26,474 7.82%
Holding current value
$419,243
Previous $367,000 2.18%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$13.4 - $17.73 $27,751 - $36,718
-2,071 Reduced 7.82%
24,403 $359,000
Q2 2024

Aug 05, 2024

SELL
$13.01 - $15.77 $4,137 - $5,014
-318 Reduced 1.19%
26,474 $367,000
Q1 2024

May 03, 2024

SELL
$14.06 - $16.79 $335,176 - $400,256
-23,839 Reduced 47.08%
26,792 $421,000
Q4 2023

Feb 05, 2024

BUY
$11.67 - $20.73 $5,799 - $10,302
497 Added 0.99%
50,631 $819,000
Q3 2023

Nov 06, 2023

BUY
$12.15 - $17.85 $345,521 - $507,618
28,438 Added 131.07%
50,134 $616,000
Q2 2023

Jul 27, 2023

BUY
$14.1 - $19.83 $423 - $594
30 Added 0.14%
21,696 $348,000
Q1 2023

May 02, 2023

SELL
$9.09 - $19.45 $44,768 - $95,791
-4,925 Reduced 18.52%
21,666 $377,000
Q4 2022

Feb 10, 2023

BUY
$6.45 - $12.07 $774 - $1,448
120 Added 0.45%
26,591 $245,000
Q4 2022

Feb 09, 2023

SELL
$6.45 - $12.07 $257,135 - $481,182
-39,866 Reduced 60.1%
26,471 $244,000
Q3 2022

Nov 02, 2022

SELL
$7.86 - $12.91 $3,301 - $5,422
-420 Reduced 0.63%
66,337 $571,000
Q2 2022

Aug 01, 2022

SELL
$7.06 - $13.97 $198,315 - $392,417
-28,090 Reduced 29.62%
66,757 $544,000
Q1 2022

May 04, 2022

BUY
$12.15 - $35.28 $141,960 - $412,211
11,684 Added 14.05%
94,847 $896,000
Q4 2021

Feb 07, 2022

SELL
$30.49 - $48.49 $14.1 Million - $22.4 Million
-462,445 Reduced 84.76%
83,163 $2.84 Million
Q3 2021

Nov 02, 2021

BUY
$41.66 - $52.52 $5.08 Million - $6.41 Million
122,020 Added 28.81%
545,608 $26.3 Million
Q2 2021

Aug 03, 2021

BUY
$36.62 - $51.69 $10.9 Million - $15.4 Million
297,845 Added 236.87%
423,588 $19.1 Million
Q1 2021

May 04, 2021

BUY
$41.56 - $59.88 $1.37 Million - $1.97 Million
32,924 Added 35.47%
125,743 $6.06 Million
Q4 2020

Feb 01, 2021

SELL
$36.08 - $56.47 $162,648 - $254,566
-4,508 Reduced 4.63%
92,819 $5 Million
Q3 2020

Nov 09, 2020

SELL
$33.26 - $40.48 $44,668 - $54,364
-1,343 Reduced 1.36%
97,327 $3.59 Million
Q2 2020

Aug 07, 2020

SELL
$24.21 - $31.02 $4.26 Million - $5.45 Million
-175,837 Reduced 64.06%
98,670 $3.06 Million
Q1 2020

May 04, 2020

SELL
$20.5 - $34.53 $122,754 - $206,765
-5,988 Reduced 2.13%
274,507 $7.58 Million
Q4 2019

Feb 06, 2020

BUY
$18.96 - $29.84 $15,471 - $24,349
816 Added 0.29%
280,495 $8.2 Million
Q4 2019

Feb 04, 2020

SELL
$18.96 - $29.84 $677,687 - $1.07 Million
-35,743 Reduced 11.33%
279,679 $9.01 Million
Q3 2019

Nov 12, 2019

BUY
$19.12 - $26.24 $4.89 Million - $6.71 Million
255,662 Added 427.81%
315,422 $6.03 Million
Q1 2019

May 03, 2019

SELL
$12.14 - $20.46 $215,970 - $363,983
-17,790 Reduced 22.94%
59,760 $1.22 Million
Q4 2018

Feb 05, 2019

SELL
$11.24 - $18.5 $1.31 Million - $2.16 Million
-116,550 Reduced 60.05%
77,550 $978,000
Q3 2018

Nov 01, 2018

BUY
$12.5 - $15.38 $2.43 Million - $2.99 Million
194,100 New
194,100 $2.98 Million

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.16B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.